The specialised industry knowledge and scientific strength combined with the modern facilities of the two companies ensures to offer first-in-class quality control and biosafety testing services upon which manufacturers of biopharmaceuticals can rely as an extension of their own quality control teams. This partnership will enable ViruSure and Sinensis to offer a complete portfolio of testing services to industrial clients seeking to work with high-quality service providers.
As pharmaceutical companies strive to consolidate their outsourcing activities to a reduced number of critical service providers, it is felt that this partnership adds value to the proposition that both companies currently offer to the market. Joining forces ensures the offer of a wide range of solutions to the specific challenges customers face. ViruSure (www.virusure.com), based in Vienna, Austria, is a leading player in the field of virus and prion testing services to the international life sciences market. The company has a 10-year track record of strong expertise in biopharmaceutical biosafety testing based on state-of-the-art technology. Sinensis (www.sinensislifesciences.com), headquartered in the Bio Science Park in Leiden, the Netherlands, is an active player with a strong portfolio of QC testing services for pharmaceutical chemistry and microbiology, biosafety testing, analytical R&D and contract manufacturing with which it serves over 700 customers around the globe.